Key result
This unit presents basic electrophysiology protocols for conducting patch clamp studies in single cell preparations and isolated human atrial myocytes to evaluate the cardiac safety of drug candidates.
Answers are grounded in this paper and cite their sources.
This protocol provides standardized patch-clamp methodologies for evaluating the proarrhythmic risk (QT prolongation) of novel compounds via HERG and native cardiac ion channel testing.
Drugs prolonging the QT interval appear to consistently inhibit the outward, rapid delayed rectifier K+ current (IKr) conveyed by the HERG channel. Hence, for determining whether a new drug candidate blocks the latter channel, this unit presents a basic electrophysiology protocol to conduct patch clamp studies in single cell preparations expressing heterologously cloned HERG channels. An additional protocol details the isolation of myocytes from specimens of human atria which are used in the study of native cardiac ion currents (INa, ICa, Ito, Isus, IK1). The results of these tests are useful for determining whether drug candidates have the desired cardiac safety profile for human use.
No takes yet. Share an insight, caveat, or question.
Crumb et al. (2003) studied this question. Patch-clamp electrophysiology protocols was evaluated. This unit presents basic electrophysiology protocols for conducting patch clamp studies in single cell preparations and isolated human atrial myocytes to evaluate the cardiac safety of drug candidates.
Synapse has enriched 10 related papers. Consider them for comparative context: